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investigations in the prediction of the outcome of chronic
foot ulcers.15 The reproducibility of tcPO2 was investigated
earlier in healthy volunteers and in patients with PAOD and
seems acceptable when the measurements are performed
during submaximal vasodilatation by heating the investi-
gated skin area to a core temperature of 44°C.9,16-19
However, in patients with PAOD and chronic foot ulcers,
the disturbances in skin microcirculation may differ from
one skin area to another.20 The aim of this study was to
investigate tcPO2 in two different skin areas at the foot dor-
sum and to investigate the day-to-day variability of tcPO2 in
patients with diabetes mellitus and PAOD who are at risk
for chronic foot ulceration. The day-to-day variability of
tcPO2 during inhalation of 100% oxygen was also investi-
gated, because the predictive value of tcPO2 for ulcer heal-
ing may be enhanced by this procedure.14
METHODS
Patients. Ten male patients with type 2 diabetes mel-
litus and PAOD were studied. Eight patients had had
chronic foot ulcers for more than 8 weeks, and two
patients had a history of earlier foot ulceration. The mean
age of the patients was 65 ± 13 years, and the mean dura-
tion of diabetes mellitus in the patients was 33 ± 6 years.
Four patients were smokers, and six patients were ex-
smokers. All patients were treated with insulin two to four
times daily. One patient had undergone vascular recon-
struction 5 weeks before the investigations. Because of the
extensive distal nature of the PAOD or the PAOD and an
increased operative risk, the patients were not eligible for
reconstructive vascular surgery or angioplasty. None of the
patients had any clinical signs of ongoing acute infection.
Chronic foot ulceration is a severe complication in
patients with diabetes mellitus, and 10% to 15% of these
lesions deteriorate, leading to minor or major amputation
of the limb.1,2 Peripheral arterial occlusive disease (PAOD)
is a common cause of chronic foot ulcers,1,2 and the
impaired tissue oxygenation is further deteriorated by dis-
turbances in skin microcirculation of the diabetic foot.3,4
These disturbances are characterized by an impaired capil-
lary blood circulation, which is more pronounced when the
demand of tissue nutrition and oxygenation is increased.3,4
This “chronic capillary ischemia” can be demonstrated early
after the onset of diabetes mellitus, is more pronounced
when other diabetic complications are present,4 and may be
one explanation for the reduced transcutaneous oxygen ten-
sion (tcPO2) shown in patients with diabetes mellitus.5-7
The tcPO2 is a noninvasive method reflecting local arterial
skin blood flow and oxygenation8 and can be used as a
means of determining severity and clinical progression of
PAOD, chronic foot ulceration, or both.9-12 The tcPO2 is
also a useful means of determining the optimal amputation
level8,9,13,14 and can be a complement to macrocirculatory
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Purpose: We evaluated the day-to-day variability of transcutaneous oxygen tension (tcPO2) in patients with diabetes
mellitus and peripheral arterial occlusive disease who were at risk for chronic foot ulceration.
Methods: The tcPO2 was measured in the morning once daily for 3 consecutive days in 10 male patients with diabetes
mellitus who were hospitalized. The mean age of the patients was 65 ± 13 years, and they had a mean duration of dia-
betes mellitus of 33 ± 6 years. The tcPO2 was measured at a reference point at the chest (I2 dx), the dorsum of the
foot, and in the first intermetatarsal space. Measurements of tcPO2 in the first intermetatarsal space were performed
before and during inhalation of 100% oxygen.
Results: The mean tcPO2 was higher (P < .001) at I2 dx (56 ± 10 mm Hg) than at the dorsum of the foot (25 ± 19
mm Hg) and first intermetatarsal space (27 ± 20 mm Hg). tcPO2 increased (P < .001) during inhalation of 100% oxy-
gen, whereas the increase was severely reduced in three patients with tcPO2 less than 10 mm Hg at baseline. A reason-
ably good day-to-day variability of tcPO2 was seen; the linear relations between tcPO2 investigated on days 1, 2, and
3 were highly significant (P = .0001) at each measuring site, and no systematic differences were seen between the
repeated measurements (analysis of variance; P = .13 to .85).
Conclusion: The results show an acceptable day-to-day variability of tcPO2, both at baseline and during oxygen inhala-
tion, in patients with diabetes mellitus and peripheral arterial occlusive disease. (J Vasc Surg 2001;34:277-82.)
Examining procedure. Measurements of tcPO2, sys-
tolic and diastolic arm blood pressures, and systolic toe
blood pressure were performed on three consecutive days
(days 1, 2, and 3) at the Microcirculatory Laboratory of
Karolinska Hospital. The measurements were made in the
morning after the patients had eaten a light breakfast and
approximately 90 minutes after insulin injection. The
patients were asked to refrain from smoking and drinking
coffee for at least 2 hours before the examinations. No
change in the medical treatment was made during the
study period. tcPO2 and peripheral blood pressure were
measured with the patient in the supine position, after an
acclimatization period of 20 minutes. The room tempera-
ture was kept between 22°C and 24°C. If the patient had
foot ulceration, the foot with ulceration was chosen for
the examinations.
Blood pressure measurement. Systolic and diastolic
arm blood pressures (mm Hg) were measured by means of
the Riva Rocci method. The systolic toe blood pressure
was assessed by recording the pressure (mm Hg) with a
miniature cuff (2 cm wide) placed around the base of the
great toe, in which return of blood was shown by means
of laser Doppler fluxmetry of the toe pulp when the cuff
was slowly deflated from suprasystolic values.21 This
method is highly correlated (r = 0.985; P < .001) to pres-
sure measurements with photopletysmography.21
Transcutaneous oxygen tension. The tcPO2 mea-
surement was made with an electrochemical transducer
(Oxykapnomonitor, SMK 363 Hellige, Freiburg im
Breisgau, Germany). The monitor was calibrated against
air and a zero solution, according to the manufacturer’s
instructions. The measurement site was cleaned carefully
with disinfection solution (chlorhexidin spirit), and the
probe was attached to the skin with double-sided adhesive
rings and contact liquid supplied by the manufacturer. To
increase the permeability of the skin to oxygen molecules
at the measuring site, we heated the transducer to 44°C
with a built-in sensor heater. Hyperemic stabilization
occurred within 20 minutes, and the tcPO2 signal was
continuously recorded on paper. A reference value was
determined by placing the transducer on the chest at the
right side in the subclavicular region (I2 dx).8 The trans-
ducer was then placed at the dorsum of the foot (over the
dorsal pedal artery), and after a measurement was taken at
this point, the transducer was moved to the first inter-
metatarsal space. The measured skin areas were marked
with ink to ensure the same measuring site at each investi-
gation. tcPO2 in the first intermetatarsal space was mea-
sured before and during inhalation of 100% oxygen. The
patients inhaled oxygen by breathing in a plastic hood sup-
plied with oxygen for 15 to 20 minutes. After an inhala-
tion period of 5 to 10 minutes, a tcPO2 plateau was
reached and was registered as the tcPO2 level during
inhalation of 100% oxygen. None of the tcPO2 measure-
ments were performed with direct contact with any foot
ulceration.
Statistical analysis. Data of peripheral blood pres-
sures are given as mean ± SD in Table I. The results of
tcPO2 are shown in Table II as mean ± SD, and the mean
tcPO2 for days 1 through 3 was determined. The differ-
ence in tcPO2 between different measuring sites was inves-
tigated by means of the paired t test with the Bonferroni
correction. The means of the systolic toe blood pressures
and tcPO2 values at the foot were calculated in each
patient and plotted against each other in a scattergram,
and the linear relation was determined (Fig 1). The repro-
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Fig 1. Linear relation between mean systolic toe blood pressure
(mm Hg) and mean transcutaneous oxygen tension (mm Hg) at
foot in 10 patients with diabetes mellitus and PAOD.
Fig 2. Day-to-day variability of tcPO2 (mm Hg) measured at
dorsum of foot on three consecutive days (1, 2,and 3) in 10
patients with diabetes mellitus and PAOD.
ducibility was investigated by means of regression analyses
and 1-factor analysis of variance with repeated measures,
and the data are shown in Figs 2 and 3 and are given in
the “Results” section. A P value less than .05 was consid-
ered to be significant. For each patient, the within SD
(SDwithin) and mean were calculated for the three repeated
measurements of tcPO2. The within SDs and means were
then averaged for the patients. Mean and approximate
95% CIs for the within variation were given by means of
these estimates as mean ± 2*SDwithin. These data are given
in Table III.
RESULTS
Peripheral blood pressure. The toe/arm blood
pressure index was less than 0.7 in all patients. Significant
linear relations between the systolic toe blood pressures
measured on days 1, 2, and 3 (r2 = 0.89-0.93; P < .001)
was shown by means of regression analysis, and no sys-
tematic difference (analysis of variance; P = .42) was seen
between the repeated measurements.
Transcutaneous oxygen tension. The tcPO2 mea-
sured at the reference point (I2 dx) was higher (P < .01)
than that measured at the dorsum of the foot and in the
first intermetatarsal space, whereas there was no significant
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difference (P = .489) between tcPO2 measured at the dor-
sum of the foot and that measured in the first inter-
metatarsal space. tcPO2 in the first intermetatarsal space
increased (P < .001) significantly during inhalation of
100% oxygen, and the increase was more than 400% in
seven patients (without oxygen, 37 ± 11 mm Hg; with
oxygen, 243 ± 58 mm Hg). The tcPO2 level during
inhalation of 100% oxygen was considerably lower (4-33
mm Hg) in three patients with severely reduced tcPO2 at
baseline (< 10 mm Hg). No significant linear relation (r2
= 0.06, P = .42) was seen between mean systolic toe blood
pressure and mean tcPO2 at the foot (Fig 1).
Day-to-day variability of tcPO2. Highly significant
relations were shown by means of regression analyses
between tcPO2 determined on days 1, 2, and 3 at each
measuring site: I2 dx (r2 = 0.75-0.82; P < .01); dorsum of
the foot (Fig 2; r2 = 0.89-0.96; P < .001); first inter-
metatarsal space before inhalation of 100% oxygen (r2 =
0.91-0.94; P < .001); first intermetatarsal space during
inhalation of 100% oxygen (r2 = 0.91-0.95; P < .001). No
systematic differences were observed between the
repeated measurements of tcPO2 on days 1, 2, and 3
(analysis of variance; P = .17, .62, .85, .13, respectively).
Highly significant linear relations (r2 = 0.73-0.98; P <
Fig 3. Linear relations between lowest and highest transcutaneous oxygen tension (tcPO2; mm Hg) obtained in each patient at three
different measuring sites, the reference point (I2 dx; solid circle), dorsum of foot (open circle), and in first intermetatarsal space before
(dot) and during inhalation of 100% oxygen (solid box).
Table I. Systolic and diastolic arm blood pressure (mm Hg) and toe blood pressure (mm Hg) on three consecutive
days (1, 2, and 3) in 10 patients with diabetes mellitus and PAOD
Day 1 Day 2 Day 3
Arm blood pressure
Systolic (mm Hg) 135 ± 21 129 ± 16 130 ± 14
Diastolic (mm Hg) 78 ± 14 74 ± 12 75 ± 12
Toe blood pressure (mm Hg) 56 ± 44 53 ± 39 50 ± 38
Toe/arm blood pressure index 0.42 ± 0.33 0.40 ± 0.30 0.38 ± 0.29
The values are presented as mean ± SD.
.01) were seen between the lowest and highest tcPO2 val-
ues at each measuring point (Fig 3).
Mean and approximate 95% CIs for the within varia-
tion of the tcPO2 measurements are shown in Table III.
Although the CIs are formed for single new observations
for the variables in Table III, the lengths of the intervals
seem to be rather narrow, indicating a reasonably good
day-to-day variability of tcPO2.
DISCUSSION
In this study, the day-to-day variability of tcPO2 was
investigated in 10 patients with diabetes mellitus and
PAOD. All patients were at high risk for chronic foot
ulceration; 8 patients had chronic foot ulcers, and 
the other 2 patients had a history of chronic foot ulcers.
The tcPO2 was measured in three different skin areas, the
chest, the dorsum of the foot, and in the first inter-
metatarsal space.
The measurement of tcPO2 reflects the amount of
oxygen available in skin microcirculation during local
hyperemia and is dependent on both central and local fac-
tors. The central factors may be systolic arterial blood
pressure and arterial oxygen content, which are influenced
by such factors as heart failure and respiratory diseases,
whereas the local factors, such as local blood flow, local
oxygen consumption, and diffusion, are influenced by
such factors as angiopathy, infection, edema, and skin
thickness. tcPO2 in patients with diabetes mellitus is gen-
erally somewhat lower than in age-matched control sub-
jects who do not have diabetes mellitus, even in patients
with a short duration of diabetes mellitus and without
macrovascular complications.5-7 In patients with PAOD,
tcPO2 can be very low or close to 0, and it has been sug-
gested that these findings do not necessarily mean total
skin anoxia, but rather that the amount of oxygen mole-
cules available at the skin surface is too low for consump-
tion by the electrode.9,22 The metabolic demand of skin
tissue is low, and skin tissue can sometimes survive despite
severely impaired blood circulation. However, tcPO2 lev-
els less than 10 mm Hg are most often associated with a
bad outcome, such as impaired ulcer healing, amputation,
or both.9,15
The results of the current study are in line with other
investigations showing a reduced tcPO2 at the foot level in
patients with diabetes mellitus and PAOD,8,9 which indi-
cates that oxygen delivery to the skin is mainly a flow-
related phenomenon. Franzeck et al9 investigated tcPO2
in healthy subjects and in patients with PAOD. In the
healthy subjects, tcPO2 varied between 40 and 70 mm Hg
at the chest level and between 30 and 70 mm Hg at the
foot. In the patients with PAOD, tcPO2 at the chest level
was between 30 and 80 mm Hg, whereas tcPO2 at the
foot varied considerably (0-70 mm Hg). In the current
study, three patients showed very low tcPO2 at baseline 
(< 10 mm Hg), and the responses during inhalation of
100% oxygen were also severely reduced (4-33 mm Hg) as
compared with those in the other patients (170-330 mm
Hg). These findings indicate an extremely impaired skin
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Table II. Transcutaneous oxygen tension (mm Hg) measured at a reference point (I2 dx), the dorsum of foot, and in
the first intermetatarsal space on three consecutive days (1, 2, and 3) in 10 patients with diabetes mellitus and PAOD
Day 1 Day 2 Day 3 Mean days 1 to 3
I2 dx (mm Hg) 57 ± 10 57 ± 12 54 ± 8 55.6 ± 9.5
Dorsum of the foot (mm Hg) 24 ± 21 25 ± 18 25 ± 18 24.6 ± 18.6*
First intermetatarsal space
Without oxygen (mm Hg) 26 ± 19 27 ± 21 27 ± 20 26.5 ± 19.5*†
With 100% oxygen (mm Hg) 163 ± 102 176 ± 128 188 ± 126 175 ± 117‡
The values are presented as mean ± SD, and the statistical analyses were performed with the paired t test with Bonferroni correction.
The measurements in the first intermetatarsal space were performed before and during inhalation of 100% oxygen.
*P < .01 as compared with I2 dx.
†No significant difference (P = .489) as compared with “dorsum of the foot.”
‡P <.01 as compared with that without oxygen.
Table III. Mean and approximative 95% CIs for the within variation (SDwithin) of transcutaneous oxygen tension (mm
Hg) during 3 consecutive days
Mean SDwithin 95% CI
I2 dx (mm Hg) 55.6 3.8 48.0-63.2
Dorsum of the foot (mm Hg) 24.6 3.2 18.2-30.8
First intermetatarsal space without 100% oxygen (mm Hg) 26.5 3.3 19.9-33.1
First intermetatarsal space with 100% oxygen (mm Hg) 175.4 21.5 132.4-218.4
The measurements were performed at a reference point (I2 dx), the dorsum of the foot, and in the first intermetatarsal space before and during inhalation
of 100% oxygen.
microcirculation,8,9,14 a suggestion strengthened because
two of these patients went on to have a major amputation
within 7 weeks. The reasons for amputation were symp-
toms of critical ischemia and not acute infection. The third
patient had undergone vascular reconstruction 5 weeks
earlier and had a slight foot edema, which may explain the
severely reduced tcPO2.23 However, this patient under-
went a major amputation 12 months later. In contrast to
the microcirculatory findings, toe blood pressure indi-
cated critical limb ischemia in only one of these three
patients (ie, a systolic toe blood pressure ≤ 30 mm Hg).24
However, two other patients had severely low toe blood
pressures, whereas the tcPO2 levels were between 30 and
50 mm Hg (Fig 1), and none of these patients went on to
have an amputation within the first year. Furthermore, the
current study showed no significant relation between
macrocirculation and microcirculation (Fig 1). This dis-
crepancy between macrovascular and microvascular find-
ings is in agreement with the results of an earlier study by
our group,15 which also indicated that tcPO2 is a better
predictor for outcome of chronic foot ulcers than toe
blood pressure. A combination of peripheral blood pres-
sure measurements and skin microcirculatory investiga-
tions, such as systolic toe blood pressure and tcPO2, may
provide better assessment of the prognosis than one
parameter alone.25,26 The reproducibility of systolic toe
blood pressure measurements, with laser Doppler fluxme-
try as the means of detection, was also investigated in this
study, and a good agreement was demonstrated between
the repeated investigations (Table I).
The tcPO2 was measured in two adjacent skin areas at
the foot because the disturbances in skin microcirculation
may have a patchy distribution.20,27 The results showed
no significant differences in tcPO2 between these two
measuring points (Table II; P = .489), which may be
because these skin areas are mainly supplied with blood
from the same artery, the dorsal pedal artery.
This study shows a good day-to-day variability for
tcPO2 measured at the chest, the dorsum of the foot, and
in the first intermetatarsal space both before and during
inhalation of 100% oxygen (Figs 2 and 3). These results
are in line with a study by Rooke and Osmundson,18 who
reported a “relatively” good agreement of the tcPO2
investigations when repeated 24 and 48 hours later.
Lukkari-Rautiarinen et al28 investigated the day-to-day
variability of tcPO2 in patients with “advanced distal
ischemia of the lower limb” and found a coefficient 
of variation of 37%, which was reduced to 31% when
patients with tcPO2 less than 10 mm Hg were excluded.
To eliminate the problem with patients with very low
tcPO2 values, we have chosen not to report the repro-
ducibility with the coefficient of variation. The reason for
the good reproducibility in this study is most probably
that we investigated a homogenous group of hospitalized
patients and the investigations were performed in a very
standardized way (same time of the day, same time after
medication). No significant difference in reproducibility of
tcPO2 was seen between the different measuring sites, but
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the reproducibility may be somewhat better in the first
intermetatarsal space when measured without oxygen
inhalation.
In summary, this study shows an acceptable day-to-
day variability for measurement of tcPO2, both at baseline
and during oxygen inhalation, in patients with diabetes
mellitus and PAOD who are at high risk for chronic foot
ulceration.
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